Clinical Trial Update: Study of ZG005 in Combination With Gecacitinib in Participants With Advanced Cervical Cancer [Phase 1, Phase 2]

View source ↗

Summary

This update reports an ongoing Phase 1/2 trial evaluating ZG005 in combination with Gecacitinib for advanced cervical cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Gecacitinib (Gecacitinib)
• ZG005

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Cervical Cancer | Phase 1, Phase 2 | Status: RECRUITING